Editor’s Note: This week, the Food and Drug Administration sent us a letter, which we have posted below, taking issue with several passages in our story about airport body scanners. The letter generally takes semantic issue with how we presented specific facts. It does not, in our judgment, raise any issues of substance.
The case of the anthrax letters has been unfolding for a decade now. Some of those involved in preparing these reports covered the story when it broke and had been investigating bio-defense issues even earlier.
International policymakers are looking for ways to rein in tax arbitrage, the practice of exploiting cross-border differences in tax laws, though companies have said they shouldn't act as 'global tax policemen.'
Thank you for your interest in republishing this story. You are are free republish it so long as you do the following:
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
If you’re republishing online, you have to link to us and to include all of the links from our story, as well as our PixelPing tag.
You can’t sell our material separately.
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
You cannot republish our photographs without specific permission (ask our Public Relations Director Minhee Cho if you’d like to).
You have to credit us — ideally in the byline. We prefer “Author Name, ProPublica.”
Copy and paste the following into your page to republish: